

<h3>Bibliografía</h3>

    <ol>
        <li>Jin RC, Voetsch B, Loscalzo J. Endogenous mechanisms of inhibition of platelet function. Microcirculation 2005;12:247-58.</li>
        <li>Aird WC. Vascular bed-specific thrombosis. J Thromb Haemost 2007;5(Suppl 1):283-91.</li>
        <li>Bauer KA, Mannucci PM, Gringeri A, Tradati F, Barzegar S, Kass BL, et al. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Blood 1992;79:2039-47.</li>
        <li>Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989;134:1087-97.</li>
        <li>Hoffman M, Whinna HC, Monroe DM. Circulating tissue factor accumulates in thrombi, but not in hemostatic plugs. J Thromb Haemost 2006;4:2092-3.</li>
        <li>Miller GJ, Howarth DJ, Attfield JC, Cooke CJ, Nanjee MN, Olszewski WL, et al. Haemostatic factors in human peripheral afferent lymph. Thromb Haemost 2000;83:42732.</li>
        <li>Hoffman M, Colina CM, McDonald AG, Arepally GM, Pedersen L, Monroe DM, et al. Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost 2007;5:1403-8.</li>
        <li>Gui T, Lin H, Jin D, Hoffman M, Straight DL, Roberts HR, et al. Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo. Blood 2002;100:153-8.</li>
        <li>Pike RN, Buckle AM, le Bonniec BF, Church FC. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans. FEBS J 2005;272:4842-51.</li>
        <li>Rau JC, Beaulieu LM, Huntington JA, Church FC. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 2007;5 (Suppl 1):102-15.</li>
        <li>Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997;90:3819-43.</li>
        <li>Girolami A, Cosi E, Ferrari S, Girolami B. Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation. J Thromb Thrombolysis 2018;45:135-41.</li>
        <li>Corral J, Vicente V. Inherited thrombophilic conditions. Hematology 2012;17(Suppl 1):163-6.</li>
        <li>Levy JH, Sniecinski RM, Welsby IJ, Levi M. Antithrombin: anti-inflammatory properties and clinical applications. Thromb Haemost 2016;115(4):712-28.</li>
        <li>España F, Medina P, Navarro S, Zorio E, Estellés A, Aznar J. The multifunctional protein C system. Curr Med Chem Cardiovasc Hematol Agents 2005;3:119-31.</li>
        <li>España F, Estellés A, Gilabert J, Andrés C, Aznar J. Inhibidores de la proteína C. Rev Iberoamer Tromb Hemostas 1989;2:29-32.</li>
        <li>Maroney SA, Mast AE. New insights into the biology of tissue factor pathway inhibitor. J Thromb Haemost 2015;13(Suppl 1):200-7.</li> 
        <li>Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev 2015;29:17-24.</li> 
        <li>Orbe J, Montes R, Páramo JÁ. The role of PAI-1 in thrombotic events. Med Clin (Barc) 1999;19;113:63-9.</li>
        <li>Heiman M, Gupta S, Khan SS, Vaughan DE, Shapiro AD. Complete Plasminogen Activator Inhibitor 1 Deficiency. In: Adam MP, et al., editor. GeneReviews<sup>®</sup>. Seattle (WA): University of Washington, Seattle; 2017: pp 1993-2017.</li>
        <li>Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004;114:409-14.</li>
        <li>Colucci M1, Semeraro N. Thrombin activatable fibrinolysis inhibitor: at the nexus of fibrinolysis and inflammation. Thromb Res 2012;129:314-9.</li>
    </ol>